Examples of how OncoSim has been used
Find examples of work that have used OncoSim for analyses or have cited OncoSim projections
All cancers
- Long-term projections of cancer incidence and mortality in Canada: The OncoSim All Cancers Model
- Cancer in Canada – Future Projections
- The Economic Burden of Cancer in Canada from a Societal Perspective
- Estimates of future cancer management costs attributable to modifiable risk factors in Canada
- Estimates of future cancer mortality attributable to modifiable risk factors in Canada
- Cancer burden attributable to risk factors
Breast cancer
- The OncoSim-Breast cancer microsimulation model
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
- The Value of All-Cause Mortality as a Metric for Assessing Breast Cancer Screening
- The OncoSim-Breast model reproduces the observed effects of a randomized screening trial
- Potential benefits of reducing breast cancer screening abnormal call rates
Cervical cancer/HPV
- Impact of the COVID-19 pandemic on the incidence and mortality of cervical cancer in Canada. Projections from OncoSim-HPV/Cervical cancer (IPV conference)
- Action plan for the elimination of cervical cancer
- Moving towards the elimination of cervical cancer: modeling the health and economic benefits of increasing HPV vaccine uptake
- Starting cervical cancer screening at 25 years of age: the time has come
- Exploring the health outcomes of various pan-Canadian cervical cancer screening programs using microsimulation modeling
- Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM)
- Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada
- Evaluation of the natural history of cancer of the cervix, implications for prevention. The Cancer Risk Management Model (CRMM) – Human papillomavirus and cervical components
Colorectal cancer
- Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
- Participatory simulation modeling to inform colorectal cancer screening in a complex remote northern health system: Canada’s Northwest Territories
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
- Simulating Results from Trials of Sigmoidoscopy Screening Using the OncoSim Microsimulation Model
- Projected Effect of Fecal Immunochemical Test Threshold for Colorectal Cancer Screening on Outcomes and Costs for Canada using the OncoSim Microsimulation Model
- Recommendations on screening for colorectal cancer in primary care
- Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada
- Family history-based colorectal cancer screening
- Comparing the health and economic impacts of two screening strategies for colorectal cancer in Canada using the Cancer Risk Management Model (CRMM)
Lung cancer
- Efficacy of Risk Prediction Models and Thresholds to Select Patients for Lung Cancer Screening
- Estimating the cost effectiveness and clinical impact of adding smoking cessation to an organized CT lung cancer screening program in Canada
- Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness
- Implementing low-dose computer tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency and duration
- Recommendations on screening for lung cancer
- Cost-effectiveness of lung cancer screening in Canada
- Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals
- Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada
- Low dose computed tomography for the screening of lung cancer in adults
- The evaluation of cancer control interventions in lung cancer using the Canadian Cancer Risk Management Model
- Costs and cost-effectiveness of smoking cessation within an organized CT lung cancer screening program
- How in the real world are lung cancer patients treated?
- Lung cancer-related clinical and economic impacts of achieving a 5% smoking rate by 2035 in Canada
- Comparing the health and economic outcomes of opportunistic lung cancer screening vs. organized lung screening using the Cancer Risk Management Model
- Annual vs. biennial lung cancer screening using the Cancer Risk Management Model to fill gaps in evidence
COVID-19 modelling
- Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
- Impact of the COVID-19 pandemic on FAECAL immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: A comparative modelling study
- The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
Other
- 2018 Cancer system performance report
- The OncoSim Model: Development and use for better decision-making in Canadian cancer control
- 2017 Cancer system performance report
- Quality and sustainability in cancer control: A system performance report
- Canadian Cancer Risk Management Model: Evaluation of cancer control
- Translating research to inform policy decisions